UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ______________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number 1-5397 __________________________ AUTOMATIC DATA PROCESSING, INC. (Exact name of registrant as specified in its charter) ____ ...

Exhibit 99.1 TFS Financial Corporation Announces First Quarter Fiscal Year 2026 Results (Cleveland, OH - January 29, 2026) - TFS Financial Corporation (NASDAQ: TFSL) (the "Company"), the holding company for Third Federal Savings and Loan Association of Cleveland (the "Association"), today announced results for the quarter ended December 31, 2025. "We have had a positive start to our fiscal year as we quickly adapted to three recent Fed rate cuts," said Chairman and CEO Marc A. Stefanski. "Our net interest i ...

Exhibit 99.1 Sandisk Reports Fiscal Second Quarter 2026 Financial Results News Summary MILPITAS, Calif. — January 29, 2026 — Sandisk Corporation (Nasdaq: SNDK) today reported fiscal second quarter financial results. "This quarter's performance underscores our agility in capitalizing on better product mix, accelerating enterprise SSD deployments, and strengthening market demand dynamics, all at a time when the critical role that our products play in powering AI and the world's technology is being recognized, ...

Financial Performance - Net income for Q4 2025 was $5.3 million, with diluted EPS of $0.60, while adjusted net income was $5.6 million and adjusted diluted EPS was $0.64[4]. - Net income for the three months ended December 31, 2025, was $5,289,000, a significant improvement from a net loss of $41,593,000 in the previous quarter[17]. - Earnings per share (diluted) increased to $0.60 for the three months ended December 31, 2025, compared to a loss of $4.76 in the prior quarter[17]. - Diluted earnings per share for 2026 are anticipated to be in the range of $2.35 to $2.45[13]. - Adjusted diluted earnings per share for Q4 2025 was $0.64, compared to a loss of $1.43 in Q3 2025[27]. Revenue and Income - Total revenue for Q4 2025 was $41.7 million, with adjusted total revenue increasing 21% year-over-year to $42.1 million[4]. - Total interest income for the three months ended December 31, 2025, was $78,054,000, a decrease from $84,388,000 in the previous quarter[19]. - Noninterest income for the three months ended December 31, 2025, was $11,375,000, a recovery from a loss of $24,647,000 in the previous quarter[19]. - Adjusted total revenue for the twelve months ended December 31, 2025, is $154,706,000, up from $129,989,000 in the previous year[25]. Assets and Loans - Total assets decreased to $5,571,647,000 as of December 31, 2025, from $5,639,174,000 at the end of the previous quarter[18]. - Total loan balances reached $3.7 billion, up $143.2 million, or 4%, from Q3 2025, driven by strong production in single tenant lease financing and construction[6]. - Total loans amounted to $3,746,728 thousand as of December 31, 2025, a decrease of 10.2% from $4,170,646 thousand in December 2024[22]. Deposits and Ratios - Total deposits were $4.8 billion, a slight decrease from $4.9 billion in Q3 2025, with a loans to deposits ratio of 77.4%[6]. - Total deposits decreased to $4,839,813,000 as of December 31, 2025, from $4,915,434,000 at the end of the previous quarter[18]. - Interest-bearing demand deposits increased to $1,120,850 thousand, representing 23.2% of total deposits as of December 31, 2025, up from 18.2% in December 2024[22]. Credit Losses and Provisions - Provision for credit losses for Q4 2025 was $12.0 million, down 66% from Q3 2025, with net charge-offs to average loans improving to 1.68%[6]. - Provision for credit losses increased significantly to $11,984,000 for the three months ended December 31, 2025, from $7,201,000 in the same period last year[19]. - The allowance for credit losses on loans was 1.49% as of December 31, 2025, compared to 1.66% in the previous quarter[17]. Margins and Returns - Net interest income rose 29% year-over-year to $30.3 million, with a fully-taxable equivalent net interest margin of 2.30%, an increase of 55 basis points from the prior year[4]. - The net interest margin increased to 2.22% for the three months ended December 31, 2025, up from 2.04% in the previous quarter[17]. - Return on average assets improved to 0.37% for the three months ended December 31, 2025, compared to a negative return of (2.71%) in the previous quarter[17]. - Return on average shareholders' equity was 5.79% for the three months ended December 31, 2025, compared to (42.11%) in the previous quarter[17]. Future Outlook - The company expects continued loan growth of 15% to 17% in 2026, with FTE net interest margin projected to expand to 2.75% to 2.80% by Q4 2026[13]. - The outlook for FTE net interest income in 2026 is between $155 million and $160 million, with noninterest income expected to be $33 million to $35 million[13]. - Operating expenses for 2026 are projected to be between $111 million and $112 million, with a provision for credit losses expected to be $50 million to $53 million[13].

Acquisition and Mergers - The company entered into a definitive agreement to be acquired by Blackstone Inc. and TPG Capital for $76.00 per share in cash, with a potential total consideration of $79.00 per share including a contingent value right[116] - The acquisition of Gynesonics was completed for a purchase price of $340.7 million, with $146.1 million allocated to intangible assets and $192.2 million to goodwill[120] - The company faces risks related to regulatory approvals, market conditions, and potential disruptions from the merger process[116] Business Segments - The company operates in four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health, focusing on women's health and well-being[108] - The Diagnostics segment includes molecular diagnostic assays and systems, with a focus on detecting STDs and other infectious diseases[109] - The Breast Health segment offers advanced breast imaging solutions, including 3D digital mammography systems and AI-based image analysis software[112] - The GYN Surgical segment features products like the MyoSure and NovaSure systems for treating uterine conditions, enhancing surgical options[113] - The Skeletal Health segment includes the Horizon DXA system for bone density evaluation, although the sale of Fluoroscan Insight FD systems will be discontinued[114] Financial Performance - Product revenues increased by $13.5 million, or 1.7%, to $831.4 million in the current quarter compared to $817.9 million in the prior year, driven by increases in GYN Surgical and Skeletal Health revenues[122] - Diagnostics product revenues decreased by $3.7 million, or 0.8%, primarily due to lower sales of SARS-CoV-2 assays and a decrease in Aptima CT/NG and HPV assays[123] - Breast Health product revenues decreased by $4.7 million, or 2.2%, mainly due to lower sales of digital mammography systems and Brevera 9 Gauge Needles, which were subject to a stop-ship[124] - GYN Surgical product revenues increased by $13.2 million, or 8.0%, primarily due to the Gynesonics acquisition, contributing $9.1 million[125] - Skeletal Health product revenues surged by $8.7 million, or 124.3%, due to increased sales volume of Horizon DXA systems[126] - Service and other revenues increased by $12.5 million, or 6.1%, to $216.4 million, driven by higher Breast Health service contract revenue[128] Expenses and Costs - Cost of product revenues increased by $20.8 million, or 6.9%, to $362.9 million, with the cost as a percentage of product revenues rising to 43.6% from 42.4%[130] - Operating expenses totaled $349.4 million, a decrease of $1.3 million, with selling and marketing expenses down by 6.7%[137] - General and administrative expenses rose by 10.5% to $127.8 million, primarily due to increased acquisition transaction expenses and compensation[139] - Research and development expenses increased slightly by 0.4% to $60.5 million, influenced by consulting spend related to quality organization and Gynesonics acquisition expenses[137] Interest and Income - Interest income decreased by $4.5 million (18.6%) to $19.7 million for the three months ended December 27, 2025, compared to $24.2 million in the prior year, primarily due to lower interest rates[142] - Interest expense increased by $2.9 million (9.5%) to $30.5 million for the three months ended December 27, 2025, compared to $27.6 million in the prior year, mainly due to a lower principal balance under the 2025 Credit Agreement[143] - Other income decreased significantly by $23.4 million to $0.6 million for the three months ended December 27, 2025, compared to $24.0 million in the prior year, primarily due to a loss from a strategic investment[144] - Provision for income taxes increased by $4.1 million (8.8%) to $50.6 million for the three months ended December 27, 2025, with an effective tax rate of 22.0% compared to 18.8% in the prior year[145] Segment Revenues and Operating Income - Total revenues in the Diagnostics segment decreased by $6.2 million (1.3%) to $464.4 million for the three months ended December 27, 2025, while operating income increased by $2.0 million (1.3%) to $157.5 million[148] - Total revenues in the Breast Health segment increased by $6.8 million (1.8%) to $375.9 million for the three months ended December 27, 2025, with operating income rising by $13.1 million (14.6%) to $102.8 million[150] - Total revenues in the GYN Surgical segment increased by $14.5 million (8.7%) to $180.8 million for the three months ended December 27, 2025, but operating income decreased by $18.1 million (30.9%) to $40.5 million[152] - Total revenues in the Skeletal Health segment increased significantly by $10.9 million (69.0%) to $26.7 million for the three months ended December 27, 2025, while operating income improved by $5.9 million[154] Debt and Liquidity - As of December 27, 2025, the company had total recorded debt outstanding of $2.51 billion, including $1.167 billion under the 2025 Credit Agreement[161] - Cash and cash equivalents increased by $208.5 million to $2,168.0 million during the first three months of fiscal 2026, primarily due to cash generated from operating activities[156] - The total principal balance of the 2028 Senior Notes is $400.0 million, maturing on February 1, 2028, with an interest rate of 4.625% per year[166] - The total principal balance of the 2029 Senior Notes is $950.0 million, maturing on February 15, 2029, with an interest rate of 3.250% per year[168] - A new stock repurchase program was authorized for up to $1.5 billion, with $937.5 million remaining unused as of December 27, 2025[169] - As of December 27, 2025, the fair value of the 2028 Senior Notes is approximately $400.0 million and the 2029 Senior Notes is approximately $938.7 million[176] - The aggregate principal outstanding under the 2025 Credit Agreement is $1.169 billion, which is subject to variable interest rates[178] - A hypothetical 10% increase in the SOFR rate would increase annual interest expense by approximately $2.5 million[178] - A hypothetical 100 basis point change in market rates would change annual interest income by approximately $19.4 million based on current cash and investment balances[179] - Future liquidity is contingent upon operating performance and may require additional capital for acquisitions or strategic transactions[172] Risk Factors - Future performance may be impacted by macroeconomic factors such as inflation and interest rates, affecting customer and supplier relationships[116] - The company is focused on maintaining compliance with evolving regulations and quality standards in its product offerings[116] - The company has executed forward foreign currency contracts to hedge a portion of operating results against currency exchange rate fluctuations[180] - The company believes that a hypothetical 10% increase or decrease in foreign currencies would not have a material adverse impact on its financial condition or results of operations[181]

Financial Outlook - Olin Corporation announced an updated outlook for Q4 2025 on January 8, 2026[6] - The press release includes financial results and operational performance metrics for the fourth quarter ended December 31, 2025[6] - Specific financial figures and percentage changes will be detailed in the attached press release (Exhibit 99.1)[7]

Exhibit 99.1 DECKERS BRANDS REPORTS THIRD QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS Goleta, California (January 29, 2026) -- Deckers Brands (NYSE: DECK), a global leader in designing, marketing, and distributing innovative footwear, apparel, and accessories, today announced financial results for the third fiscal quarter ended December 31, 2025. The Company also provided an update to its financial outlook for the full fiscal year ending March 31, 2026. "Deckers produced record revenue and earnings per share ...

Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2025 OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ______ Commission file number 000-25711 EXTREME NETWORKS, INC. (Exact name of registrant as specified in its charter) DELAWARE 77-0430270 [State or othe ...

For Immediate Release LPL Financial Announces Fourth Quarter and Full Year 2025 Results Fourth Quarter 2025 Key Financial Results: Key Business Results: Key Capital and Liquidity Measures: Full Year 2025 Key Financial Results: Key Business & Capital and Liquidity Results: *See the Non-GAAP Financial Measures section and the endnotes to this release for further details about these non-GAAP financial measures 1 • Net income was $301 million, translating to diluted earnings per share ("EPS") of $3.74, up 4% fr ...

Financial Performance - The company reported a significant increase in revenue, reaching $1.5 billion, representing a 20% year-over-year growth[4]. - The company provided an optimistic outlook, projecting revenue growth of 15% for the next fiscal year, targeting $1.725 billion[4]. - The company has set a performance guidance of $1.6 billion for the next quarter, reflecting a 10% increase compared to the current quarter[4]. - The company reported a consistent return on average assets of 1.8% in Q1 2023, with projections indicating growth to 2.1% in Q2 2023[21]. - NewtekOne's return on average equity was 20.2% in Q1 2023, expected to rise to 20.9% in Q2 2023[21]. - The company reported a net interest income of $22.7 million from a $300 million loan pool, which is non-GAAP defined as interest received on loans less interest paid on securitized debt[59]. - The company has experienced a consistent increase in net interest income, indicating strong operational performance[59]. - The company reported a GAAP net income of $9,650,000 for the quarter ending March 31, 2024, with an adjusted net income of $9,250,000[67]. - Total income for the quarter was $58,273,000, showing a solid revenue generation capability[67]. - Net income for the quarter ending March 31, 2023, was $18,550 million, with a return on average tangible common equity of 36.3%[65]. User Growth and Customer Engagement - User data showed a total of 5 million active users, up from 4 million in the previous quarter, indicating a 25% increase[4]. - Customer retention rates improved to 85%, up from 80% last year, showcasing enhanced user satisfaction[4]. - Customers visit their depositary source 3-5 times per week and 12-20 times per month primarily to manage money and check account balances[12]. - The company generates approximately 600 new referrals per day as a client acquisition tool[29]. - The company aims to grow deposits by offering a superior digital experience that attracts and retains business clients[33]. Strategic Initiatives and Market Expansion - The company is expanding its market presence in Europe, aiming for a 30% increase in market share by the end of the next fiscal year[4]. - A strategic acquisition of a smaller tech firm was announced, expected to enhance product offerings and drive future growth[4]. - Newtek One's mission remains unchanged since its formation in 1998, focusing on providing business and financial solutions to independent business owners in the United States[8]. - The acquisition of the National Bank of New York City enhances the company's business and financial solutions offerings to independent business clients[12]. - The company is focused on expanding its market presence and enhancing product offerings through ongoing research and development initiatives[67]. Technology and Innovation - The company emphasizes its technological advantage in banking and the use of AI to enhance service delivery[6]. - The company utilizes proprietary and patented advanced technological solutions to effectively acquire customers and manage its lending operations[10]. - The integration of AI technology is a key focus area for enhancing banking services and operational efficiency[37]. - The new offerings utilize AI to automate financial data reviews and streamline the underwriting and closing processes, enhancing efficiency[43]. - The company is focused on expanding its market presence through innovative digital applications and fully online processes for loan offerings[45]. Operational Efficiency - NewtekOne demonstrated an improving operating efficiency ratio, reaching 83% in Q1 2023, up from 76% in Q4 2022[19]. - The efficiency ratio improved to 183.1% for the quarter, showcasing better operational efficiency compared to previous periods[65]. - The efficiency ratio improved to 170.6%, showcasing better cost management compared to previous quarters[67]. - The company aims to reduce operational costs through automation and digitization[39]. - The company has automated workflows to handle growth without increasing headcount, enhancing operational efficiency[39]. Risk Management and Compliance - The company highlighted risks related to economic conditions and regulatory changes that could impact future performance[4]. - The company has built-in regulatory compliance workflows that are fully compliant with banking regulations and audit requirements[41]. - The company emphasizes that AI is not used for loan decisioning or direct conversations with applicants, ensuring compliance and risk management[43]. Financial Metrics and Shareholder Value - The company's book value per share has increased by 45% from $8.06 to $11.72 since transitioning to a financial holding company in Q1 2023[16]. - Tangible common book value per share has risen by 62% from $6.92 to $11.22 during the same period[16]. - The company has distributed $2.05 of common dividends per share over the eleven quarters since the transition[16]. - The tangible book value per common share rose to $170.199, demonstrating growth in shareholder value[65]. - The average total shareholders' equity increased to $1,287,831,000, reflecting a growth trend in shareholder value[67].